期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 12周，或約稿

This journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.

本期刊旨在回顧腫瘤學(xué)領(lǐng)域最重要的、最近發(fā)表的治療方案進(jìn)展。通過(guò)提供國(guó)際專(zhuān)家的清晰、有見(jiàn)地、平衡的貢獻(xiàn)，本期刊旨在促進(jìn)全球癌癥治療方法的發(fā)展。

我們通過(guò)任命國(guó)際權(quán)威人士擔(dān)任關(guān)鍵主題領(lǐng)域的分部編輯來(lái)實(shí)現(xiàn)這一目標(biāo)，這些主題包括內(nèi)分泌腫瘤、淋巴瘤、神經(jīng)腫瘤學(xué)以及乳腺癌、頭頸癌、肺癌、皮膚癌、胃腸道癌和泌尿生殖系統(tǒng)癌。分部編輯則選擇由頂尖專(zhuān)家撰寫(xiě)綜合評(píng)論文章的主題，這些文章強(qiáng)調(diào)新發(fā)展和最近發(fā)表的重要論文，并通過(guò)帶注釋的參考文獻(xiàn)列表突出顯示。我們還提供知名腫瘤學(xué)家的評(píng)論，國(guó)際編輯委員會(huì)審查年度目錄，推薦對(duì)其國(guó)家/地區(qū)特別感興趣的文章，并確保主題是最新的并包括新興研究。

《Current Treatment Options In Oncology》(目前腫瘤學(xué)的治療方案)編輯部通訊方式為SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢(xún)我們的客服老師。我們專(zhuān)注于期刊咨詢(xún)服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。